CBT Versus a Return to Work Intervention for Patients With Common Mental Illness in Primary Care
CBT vs RTW I
Cognitive Behavior Therapy Versus a Return to Work Intervention for Sick-listed Patients With Common Mental Illness in Primary Care: a Randomized Clinical Trial
1 other identifier
interventional
211
1 country
1
Brief Summary
Background: Common mental illness, such as anxiety disorders and depression, is the main cause for sick leave in Sweden. Cognitive behavior therapy (CBT) has been shown to be effective in alleviating target symptoms of these disorders, but its effect on sick leave rates has not been sufficiently addressed. The investigators have developed an intervention called return to work (RTW), which is based in cognitive behavioral theory, that has a primary aim of helping sick-listed patients with common mental illness return to work. This new treatment has not been evaluated in a randomized controlled trial. Aims: The aim of this study is to investigate the effect of CBT and RTW for common mental illness in a randomized controlled trial conducted in primary care. Participants will be randomized to diagnosis specific CBT (n=70), RTW (n=70), or a combination of the two treatments (n=70). Main outcomes are days of sick leave and clinician severity rating of psychiatric symptoms. This study could contribute to new knowledge regarding how to best treat patients on sick leave with common mental illness.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_3
Started Sep 2012
Typical duration for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 5, 2012
CompletedFirst Posted
Study publicly available on registry
July 10, 2012
CompletedStudy Start
First participant enrolled
September 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2015
CompletedMarch 3, 2016
March 1, 2016
3.2 years
July 5, 2012
March 2, 2016
Conditions
Outcome Measures
Primary Outcomes (2)
Sick leave
Number of days on sick leave
1 year
Clinician Severity Rating (CSR)
Change in CSR at post-treatment, 26 week follow-up, and 52 week follow-up compared to baseline.
Baseine, post-treatment (variable depending on disorder), 26 week follow-up, 52 week follow-up
Secondary Outcomes (15)
Montgomery-Ã…sberg Depression Rating Scale-Self-report (MADRS-S)
Baseline, post-treatment (variable depending on disorder), 26 week follow-up, 52 week follow-up
Work ability index (WAI)
Baseline, post-treatment (variable depending on disorder), 26 week follow-up, 52 week follow-up
Insomnia Severity Index (ISI)
Baseline, post-treatment (variable depending on disorder, 26 week follow-up, 52 week follow-up
Health Anxiety Inventory (HAI)
Baseline, post-treatment (variable depending on disorder), 26 week follow-up, 52 week follow-up
Perceived Stress Scale (PSS)
Baseline, post-treatment (variable depending on disorder), 26 week follow-up, 52 week follow-up
- +10 more secondary outcomes
Other Outcomes (1)
Inflammatory cytokines
Baseline, post-treatment (variable depending on disorder)
Study Arms (3)
Cognitive Behavior Therapy
ACTIVE COMPARATORAs the trial will include several different common mental disorders, the cognitive behavior therapy used in the study will be based on the protocols with best empirical support. Cognitive behavior therapy entails psychoeducational components, i.e. the patient is learns about the disorder and how to view it from a cognitive behavioral perspective. The most important part of the treatment is systematic behavior changes often targeted at exposure to feared stimuli. This is combined with cognitive interventions targeted at challenging negative automatic thoughts. All treatments will be delivered by licensed psychologists.
Return to work
EXPERIMENTALParticipants randomized to this arm will receive an experimental treatment, based in cognitive behavioral therapy, with primary aim to help patients return to work. Interventions are aimed at solving work-related problems and comprises problem-solving training and systematic employer-patient meetings aimed at facilitating a gradual return to the workplace. Licensed psychologists deliver all treatments.
CBT and Return to work
EXPERIMENTALParticipants randomized to this arm will receive a combination of cognitive behavior therapy and the return to work treatment. This arm is included in the study as the clinically most relevant therapy, would the return to work treatment be effective in reducing sick leave, is a treatment were patients are provided support to return to work but also is clinically effective in reducing psychiatric symptoms.
Interventions
Cognitive behavior therapy entails psychoeducational components, i.e. the patient is learns about the disorder and how to view it from a cognitive behavioral perspective. The most important part of the treatment is systematic behavior changes often targeted at exposure to feared stimuli. This is combined with cognitive interventions targeted at challenging negative automatic thoughts. All treatments will be delivered by licensed psychologists.
Participants randomized to this arm will receive an experimental treatment, based in cognitive behavioral therapy, with primary aim to help patients return to work. Interventions are aimed at solving work-related problems and comprises problem-solving training and systematic employer-patient meetings aimed at facilitating a gradual return to the workplace. Licensed psychologists deliver all treatments.
Eligibility Criteria
You may qualify if:
- Have been on sick leave (at least 50%) for at least 1 month and not more than 6 months
- Have an anxiety disorder diagnosis (obsessive compulsive disorder, social phobia, panic disorder, generalized anxiety disorder, post-traumatic stress disorder, specific phobia), or/and major depression, or/and maladaptive stress reaction, or/and primary insomnia
You may not qualify if:
- A lower score than 4 on the Clinician severity rating scale
- A higher score than 6 on the Clinician severity rating scale
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Karolinska Institutetlead
- Region Stockholmcollaborator
Study Sites (1)
Karolinska Institutet and Gustavsberg primary care center
Stockholm, Stockholm County, 13440, Sweden
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
July 5, 2012
First Posted
July 10, 2012
Study Start
September 1, 2012
Primary Completion
December 1, 2015
Study Completion
December 1, 2015
Last Updated
March 3, 2016
Record last verified: 2016-03